Lawmakers Urge FDA to Get Moving on Drug Supply Chain Security

Drug Industry Daily
The FDA should publish a rulemaking notice on the roles that third-party companies play in the security of the nation’s drug supply “without delay,” the House Appropriations Committee said Monday ahead of a vote on the agency’s fiscal year 2020 budget.

To View This Article:


Subscribe To Drug Industry Daily